Fundraising Fox
/Companies
Sign in

Rigimmune

Farmington, US · 1 known investors

Find your way into Rigimmune

Sign up to see every warm intro you have to Rigimmune

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Rigimmune team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

RIGImmune is a biotechnology company developing stem loop RNA (SLR) therapeutics that activate the RIG-I innate immune sensor and the Type I interferon pathway for use against serious respiratory diseases. It operates a non-lipid-nanoparticle delivery platform called NEED (Nano-Emulsion Enhanced Delivery) for delivering RNA therapeutics directly to the respiratory tract.

BiotechHealthtechMedical Devices

Founders & leadership

AM
Anna Marie PyleCo-founderCo-founder of RIGImmune, a biotechnology company developing RNA therapeutics for respiratory diseases. Pyle's research background spans RNA structural biology, viral and immune-related RNA mechanisms, and protein-RNA interactions using biophysical and crystallographic methods.
AI
Akiko IwasakiCo-founderAkiko Iwasaki studies viral infectious diseases and antiviral immunity, with expertise in the interplay between endogenous retroviruses and immune system mechanisms. She is co-founder of RIGImmune, a biotechnology company developing stem loop RNA therapeutics for respiratory diseases.

Investors · 1

Founder mafia

3 people who came through Rigimmune went on to found or lead other companies.

Anna Marie PyleCo-founderFounded RNA ConnectAkiko IwasakiCo-founderFounded Xanadu BioKazuhiro ItoChief Scientific OfficerFounded Pulmocide

Related companies · 3

VerImmuneVerImmune develops immunotherapy medicines that redirect pre-existing immune memory toward cancer cells to achieve tumor destruction with low toxicity. The company targets cancer patients across a broad range of cancer types.
InimmuneInimmune is a clinical-stage biotech company developing immunotherapies for allergy, cancer, infectious, and autoimmune diseases. The company combines immunology and vaccine expertise to advance its clinical and pre-clinical pipeline.
BellBrook LabsBellBrook Labs supplies life-science research products and services to laboratories, distributed internationally through regional partners across Europe, Asia, and Oceania. Its offerings serve the biotechnology and drug-discovery research market.

Companies working in the same space as Rigimmune.

Frequently asked questions

What does Rigimmune do?
RIGImmune is a biotechnology company developing stem loop RNA (SLR) therapeutics that activate the RIG-I innate immune sensor and the Type I interferon pathway for use against serious respiratory diseases. It operates a non-lipid-nanoparticle delivery platform called NEED (Nano-Emulsion Enhanced Delivery) for delivering RNA therapeutics directly to the respiratory tract.
Who founded Rigimmune?
Rigimmune was founded by Anna Marie Pyle, Akiko Iwasaki.
Who are Rigimmune's investors?
Rigimmune's investors include F-Prime Capital.
Where is Rigimmune headquartered?
Rigimmune is headquartered in Farmington, US.